A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Clinical trial NCT07042100 · RECRUITING
Trial details
- NCT number
- NCT07042100
- Sponsor
- Sun Pharma Advanced Research Company Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2028-08-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.